ACKR4 and neoplasm: However, CCRL1 was also shown to execute opposite effects as an inhibitor of tumor cell proliferation, a reduction in EMT properties, and the tumor cell migration in breast-cancer, hepatocellular, and, nasopharyngeal carcinoma [7,8,9].